Pyxis Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laurion Capital Management LP(6.15%),Benjamin Alexander Smith(6.15%), etc.
Pyxis Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bayer World Investments B.V.(4.7%),Bayer Aktiengesellschaft(4.7%)
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director Metzger Michael A
Pyxis Oncology | 3: Initial statement of beneficial ownership of securities-Director Metzger Michael A
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director Palani Santhosh
Pyxis Oncology | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lara Sullivan(8.89%)
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Lara
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director FLAVIN JOHN L
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director Civik Thomas
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director HUMPHREY RACHEL
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Connealy Pamela Ann
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director Cline Darren S
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director Lewis-Hall Freda C
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director Dupont Jakob
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Wadhane Jitendra
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director Palani Santhosh
Pyxis Oncology | 3: Initial statement of beneficial ownership of securities-Director Palani Santhosh
Pyxis Oncology | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(7.87%),Deep Track Biotechnology Master Fund, Ltd.(7.87%), etc.
Pyxis Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(0.0%),Tang Capital Management, LLC(0.0%), etc.
Pyxis Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%), etc.
No Data
No Data